PALI insider transactions
Palisade Bio Inc. (PALI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for PALI
- Director Baltera Robert Jr. bought $88,698 worth of shares (45,000 units at $1.97), increasing direct ownership by 11% to 461,904 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Baltera Robert Jr. bought $102,084 worth of shares (50,000 units at $2.04), increasing direct ownership by 14% to 416,904 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Chief Medical Officer Jones Mitchell Lawrence converted options into 131,167 shares and sold $106,536 worth of shares (51,880 units at $2.05), increasing direct ownership by 539% to 94,009 units (SEC Form 4) to satisfy tax liability4 - PALISADE BIO, INC. (0001357459) (Issuer)
- CEO, CFO Finley John David exercised 335,300 shares at a strike of $0.00 and sold $303,343 worth of shares (146,798 units at $2.07), increasing direct ownership by 646% to 217,688 units (SEC Form 4) to cover withholding tax4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Baltera Robert Jr. bought $59,400 worth of shares (30,000 units at $1.98), increasing direct ownership by 9% to 366,904 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Baltera Robert Jr. was granted 336,904 shares (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 3 filed by new insider Baltera Robert Jr.3 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Wei Binxian was granted 592,300 shares and converted options into 20,200 shares, increasing direct ownership by 71,637% to 613,355 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Williams Donald Allen converted options into 60,666 shares and was granted 1,498,900 shares, increasing direct ownership by 14,537% to 1,570,294 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Chuang Emil was granted 592,300 shares and converted options into 20,200 shares (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Zwick Jordan Michael was granted 336,904 shares (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 3 filed by new insider Zwick Jordan Michael3 - PALISADE BIO, INC. (0001357459) (Issuer)
- Chief Medical Officer Jones Mitchell Lawrence converted options into 8,000 shares and sold $3,481 worth of shares (1,989 units at $1.75), increasing direct ownership by 83% to 13,263 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- CEO, CFO Finley John David converted options into 13,333 shares and sold $6,818 worth of shares (3,896 units at $1.75), increasing direct ownership by 53% to 27,353 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jones Mitchell Lawrence4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by CEO, CFO Finley John David4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Amendment: SEC Form 4 filed by Director Williams Donald Allen4/A - PALISADE BIO, INC. (0001357459) (Issuer)
- Amendment: SEC Form 4 filed by Director Wei Binxian4/A - PALISADE BIO, INC. (0001357459) (Issuer)
- Amendment: SEC Form 4 filed by Director Chuang Emil4/A - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Williams Donald Allen4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Wei Binxian4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jones Mitchell Lawrence4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by CEO, CFO Finley John David4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Chuang Emil4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jones Mitchell Lawrence4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by CEO, CFO Finley John David4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Wei Binxian4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Chuang Emil4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Williams Donald Allen4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Chuang Emil4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 3 filed by new insider Chuang Emil3 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Jones Mitchell Lawrence4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by CEO, CFO Finley John David4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Wei Binxian converted options into 388 units of Comon Stock, increasing direct ownership by 83% to 855 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Williams Donald Allen converted options into 388 units of Comon Stock, increasing direct ownership by 114% to 728 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Wei Binxian4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Fischbein Margery B.4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 4 filed by Director Williams Donald Allen4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Wei Binxian converted options into 465 units of Comon Stock, increasing direct ownership by 23,250% to 467 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Director Williams Donald Allen converted options into 340 units of Comon Stock (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David converted options into 7,068 shares and covered exercise/tax liability with 2,033 shares, increasing direct ownership by 60% to 13,472 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Jones Mitchell Lawrence converted options into 4,290 shares and covered exercise/tax liability with 1,271 shares, increasing direct ownership by 362% to 3,852 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Williams Donald Allen bought $4,863 worth of Comon Stock (1,000 units at $4.86) (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David bought $4,810 worth of shares (1,000 units at $4.81), increasing direct ownership by 13% to 8,437 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David was granted 666 shares, increasing direct ownership by 10% to 7,437 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- SEC Form 3 filed by new insider Fischbein Margery B.3 - PALISADE BIO, INC. (0001357459) (Issuer)
- Jones Mitchell Lawrence converted options into 460 shares and covered exercise/tax liability with 137 shares, increasing direct ownership by 63% to 833 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David converted options into 443 shares and covered exercise/tax liability with 128 shares, increasing direct ownership by 5% to 6,771 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David converted options into 5,558 shares, increasing direct ownership by 6% to 96,849 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Neal James R converted options into 10,920 shares (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Csimma Cristina converted options into 12,800 shares, increasing direct ownership by 20,645% to 12,862 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Trenschel Robert J. converted options into 10,920 shares (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Diaz Stephanie converted options into 12,800 shares (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Jones Mitchell Lawrence converted options into 6,891 shares and covered exercise/tax liability with 2,153 shares, increasing direct ownership by 162% to 7,662 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David converted options into 6,642 shares, increasing direct ownership by 8% to 91,291 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David bought $4,692 worth of shares (10,000 units at $0.47), increasing direct ownership by 13% to 84,649 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Finley John David bought $5,590 worth of shares (10,000 units at $0.56), increasing direct ownership by 15% to 74,649 units (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)
- Williams Donald Allen bought $6,050 worth of shares (10,000 units at $0.60) (SEC Form 4)4 - PALISADE BIO, INC. (0001357459) (Issuer)